Antibiotic susceptibility of Haemophilus influenzae strains isolated from various clinical sources in Hokkaido Prefecture, Japan
暂无分享,去创建一个
S. Yokota | N. Fujii | Tasuku Hayashi | Kiyoshi Sato | Yasuo Ohkoshi | Osamu Kuwahara | Hirotsugu Akizawa | K. Matsuda
[1] S. Yokota,et al. Emergence of Fluoroquinolone-Resistant Haemophilus influenzae Strains among Elderly Patients but Not among Children , 2007, Journal of Clinical Microbiology.
[2] M. Jacobs,et al. Antimicrobial Resistance in Haemophilus influenzae , 2007, Clinical Microbiology Reviews.
[3] J. Campos,et al. Fluoroquinolone Resistance in Haemophilus influenzae Is Associated with Hypermutability , 2007, Antimicrobial Agents and Chemotherapy.
[4] K. Ubukata,et al. Molecular Evolution of β-Lactam-Resistant Haemophilus influenzae: 9-Year Surveillance of Penicillin-Binding Protein 3 Mutations in Isolates from Japan , 2006, Antimicrobial Agents and Chemotherapy.
[5] Akira Watanabe,et al. Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan , 2006, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[6] M. Kaku,et al. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan. , 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[7] J. Mott,et al. Identification of the Haemophilus influenzae tolC Gene by Susceptibility Profiles of Insertionally Inactivated Efflux Pump Mutants , 2004, Antimicrobial Agents and Chemotherapy.
[8] N. Lee,et al. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. , 2004, International journal of antimicrobial agents.
[9] T. Tsuchiya,et al. Molecular Cloning and Characterization of the HmrM Multidrug Efflux Pump from Haemophilus influenzae Rd , 2003, Microbiology and immunology.
[10] T. Murphy. Respiratory infections caused by non-typeable Haemophilus influenzae , 2003, Current opinion in infectious diseases.
[11] K. Ubukata. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[12] S. Baba,et al. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
[13] K. Sunakawa,et al. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. , 2003, Microbial drug resistance.
[14] K. Yamamoto,et al. Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with β-Lactam Resistance in β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae , 2001, Antimicrobial Agents and Chemotherapy.
[15] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[16] H. Nikaido,et al. The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump , 1997, Journal of bacteriology.
[17] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[18] G. Jahn,et al. Origin of Haemophilus influenzae R factors , 1981, Journal of bacteriology.
[19] S. Falkow,et al. beta-lactamases and R-plasmids of Haemophilus influenzae. , 1978, Scandinavian journal of infectious diseases. Supplementum.